DRMA
Price
$0.59
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
3.85M
NNVC
Price
$1.40
Change
+$0.17 (+13.82%)
Updated
Jun 27 closing price
Capitalization
22.5M
65 days until earnings call
Interact to see
Advertisement

DRMA vs NNVC

Header iconDRMA vs NNVC Comparison
Open Charts DRMA vs NNVCBanner chart's image
Dermata Therapeutics
Price$0.59
Change-$0.00 (-0.00%)
Volume$2.71K
Capitalization3.85M
NanoViricides
Price$1.40
Change+$0.17 (+13.82%)
Volume$630.34K
Capitalization22.5M
DRMA vs NNVC Comparison Chart in %
Loading...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRMA vs. NNVC commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRMA is a Buy and NNVC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (DRMA: $0.59 vs. NNVC: $1.40)
Brand notoriety: DRMA and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRMA: 2% vs. NNVC: 303%
Market capitalization -- DRMA: $3.85M vs. NNVC: $22.5M
DRMA [@Biotechnology] is valued at $3.85M. NNVC’s [@Biotechnology] market capitalization is $22.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRMA’s FA Score shows that 1 FA rating(s) are green whileNNVC’s FA Score has 0 green FA rating(s).

  • DRMA’s FA Score: 1 green, 4 red.
  • NNVC’s FA Score: 0 green, 5 red.
According to our system of comparison, NNVC is a better buy in the long-term than DRMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRMA’s TA Score shows that 3 TA indicator(s) are bullish while NNVC’s TA Score has 3 bullish TA indicator(s).

  • DRMA’s TA Score: 3 bullish, 4 bearish.
  • NNVC’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, DRMA is a better buy in the short-term than NNVC.

Price Growth

DRMA (@Biotechnology) experienced а -13.29% price change this week, while NNVC (@Biotechnology) price change was -2.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

NNVC is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NNVC($22.5M) has a higher market cap than DRMA($3.86M). NNVC YTD gains are higher at: -2.098 vs. DRMA (-56.593). NNVC has higher annual earnings (EBITDA): -8.95M vs. DRMA (-11.65M). DRMA has more cash in the bank: 9.72M vs. NNVC (2.54M). DRMA has less debt than NNVC: DRMA (175K) vs NNVC (1.5M). DRMA (0) and NNVC (0) have equivalent revenues.
DRMANNVCDRMA / NNVC
Capitalization3.86M22.5M17%
EBITDA-11.65M-8.95M130%
Gain YTD-56.593-2.0982,698%
P/E RatioN/AN/A-
Revenue00-
Total Cash9.72M2.54M382%
Total Debt175K1.5M12%
FUNDAMENTALS RATINGS
NNVC: Fundamental Ratings
NNVC
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRMANNVC
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CALX51.301.21
+2.42%
CALIX
EXEL43.670.58
+1.35%
Exelixis
SUNE1.630.01
+0.62%
SUNation Energy Inc
LIVE15.70N/A
N/A
Live Ventures
OLP23.78-0.33
-1.37%
One Liberty Properties

DRMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRMA has been loosely correlated with PVLA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if DRMA jumps, then PVLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRMA
1D Price
Change %
DRMA100%
N/A
PVLA - DRMA
35%
Loosely correlated
+3.47%
KRRO - DRMA
28%
Poorly correlated
-3.16%
ATHA - DRMA
25%
Poorly correlated
-2.64%
NNVC - DRMA
23%
Poorly correlated
+13.82%
GLMD - DRMA
23%
Poorly correlated
+1.12%
More

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with ZNTL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then ZNTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+13.82%
ZNTL - NNVC
34%
Loosely correlated
-6.35%
CGEM - NNVC
32%
Poorly correlated
+0.13%
TYRA - NNVC
31%
Poorly correlated
N/A
GANX - NNVC
29%
Poorly correlated
+1.03%
DNTH - NNVC
29%
Poorly correlated
-2.76%
More